Seeing Is Believing
Currently out of the existing stock ratings of Sachin Jain, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).
Analyst Sachin Jain, currently employed at BAML, carries an average stock price target met ratio of 100% that have a potential upside of 30.13% achieved within 665 days. Previously, Sachin Jain worked at KEYBANK.
Sachin Jain’s has documented 13 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 06-Jun-2022.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/17/2020. The price target of $32.69 was fulfilled within 265 days with a profit of $5.15 (18.7%) receiving and performance score of 0.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$87
$2.47 (2.92%)
$78
10 months 29 days ago
(17-Nov-2024)
8/9 (88.89%)
$24.91 (40.12%)
639
Buy
$88
$3.47 (4.11%)
$82
11 months 4 days ago
(12-Nov-2024)
4/5 (80%)
$24.05 (37.61%)
315
Buy
$95
$10.47 (12.39%)
$66
1 years 2 months 5 days ago
(12-Aug-2024)
6/7 (85.71%)
$14.17 (17.53%)
501
Buy
$85
$0.47 (0.56%)
$80
1 years 4 months 17 days ago
(30-May-2024)
4/4 (100%)
$10.26 (13.73%)
414
Buy
$84
$-0.53 (-0.63%)
$85
1 years 5 months 25 days ago
(22-Apr-2024)
2/12 (16.67%)
$15.73 (23.04%)
170
What Year was the first public recommendation made by Sachin Jain?